Iterum Therapeutics PLC
ITRM0.302USD
+0.017+5.89%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
14.80MValor de mercado
PerdaP/L TTM
Mais detalhes de Iterum Therapeutics PLC Empresa
Iterum Therapeutics plc is a clinical-stage pharmaceutical company. The Company develops differentiated anti-infectives. It offers ORLYNVAH (sulopenem in an oral tablet formulation) medicine, which is an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women. Sulopenem is a potent, thiopenem antibiotic delivered intravenously which is active against bacteria that belong to the group of organisms known as gram-negatives and cause urinary tract and intra-abdominal infections. The Company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Informações de Iterum Therapeutics PLC
Código da empresaITRM
Nome da EmpresaIterum Therapeutics PLC
Data de listagemMay 25, 2018
CEOFishman (Corey N)
Número de funcionários9
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 25
Endereço3 Dublin Landings
CidadeDUBLIN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIreland
Código postalD01 C4E0
Telefone35319038354
Sitehttps://www.iterumtx.com/
Código da empresaITRM
Data de listagemMay 25, 2018
CEOFishman (Corey N)
Executivos da empresa Iterum Therapeutics PLC
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael W. Dunne, M.D.
Dr. Michael W. Dunne, M.D.
Director
Director
241.00K
+6000.00%
Mr. Corey N. Fishman
Mr. Corey N. Fishman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
137.06K
--
Ms. Beth P. Hecht, J.D.
Ms. Beth P. Hecht, J.D.
Independent Director
Independent Director
18.84K
--
Ms. Judith M. Matthews
Ms. Judith M. Matthews
Chief Financial Officer
Chief Financial Officer
8.13K
--
Mr. David G. Kelly
Mr. David G. Kelly
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joseph John (Joe) Whalen
Mr. Joseph John (Joe) Whalen
Independent Director
Independent Director
--
--
Ms. Christine Coyne
Ms. Christine Coyne
Chief Commercial Officer
Chief Commercial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael W. Dunne, M.D.
Dr. Michael W. Dunne, M.D.
Director
Director
241.00K
+6000.00%
Mr. Corey N. Fishman
Mr. Corey N. Fishman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
137.06K
--
Ms. Beth P. Hecht, J.D.
Ms. Beth P. Hecht, J.D.
Independent Director
Independent Director
18.84K
--
Ms. Judith M. Matthews
Ms. Judith M. Matthews
Chief Financial Officer
Chief Financial Officer
8.13K
--
Mr. David G. Kelly
Mr. David G. Kelly
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joseph John (Joe) Whalen
Mr. Joseph John (Joe) Whalen
Independent Director
Independent Director
--
--
Detalhamento da receita
Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: qui, 5 de fev
Atualizado em: qui, 5 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Apollon Financial LLC
1.18%
Squarepoint Capital LLP
0.83%
Dunne (Michael W)
0.45%
OneDigital Investment Advisors LLC
0.36%
Fishman (Corey N)
0.26%
Outro
96.92%
Investidores
Investidores
Proporção
Apollon Financial LLC
1.18%
Squarepoint Capital LLP
0.83%
Dunne (Michael W)
0.45%
OneDigital Investment Advisors LLC
0.36%
Fishman (Corey N)
0.26%
Outro
96.92%
Tipos de investidores
Investidores
Proporção
Investment Advisor
2.33%
Investment Advisor/Hedge Fund
0.86%
Individual Investor
0.78%
Hedge Fund
0.15%
Research Firm
0.15%
Bank and Trust
0.01%
Outro
95.72%
Participação acionária institucional
Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
53
1.86M
3.49%
-2.48M
2025Q3
51
2.44M
5.09%
-582.93K
2025Q2
52
1.58M
3.92%
-2.61M
2025Q1
55
1.53M
3.82%
-2.58M
2024Q4
58
1.64M
5.63%
-1.56M
2024Q3
56
2.45M
10.80%
+569.01K
2024Q2
63
660.22K
3.99%
-1.18M
2024Q1
68
1.18M
7.18%
-978.56K
2023Q4
68
641.88K
4.78%
-516.61K
2023Q3
72
394.43K
3.03%
-679.64K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Apollon Financial LLC
250.25K
0.47%
--
--
Sep 30, 2025
Squarepoint Capital LLP
443.97K
0.83%
-12.89K
-2.82%
Sep 30, 2025
Dunne (Michael W)
241.00K
0.45%
+6.00K
+2.55%
Nov 30, 2025
OneDigital Investment Advisors LLC
191.00K
0.36%
+30.00K
+18.63%
Sep 30, 2025
Fishman (Corey N)
137.06K
0.26%
--
--
Nov 30, 2025
CAPTRUST Financial Advisors
111.60K
0.21%
+100.10K
+870.43%
Sep 30, 2025
Gen-Wealth Partners Inc
82.05K
0.15%
+82.05K
--
Sep 30, 2025
Renaissance Technologies LLC
81.69K
0.15%
-390.21K
-82.69%
Sep 30, 2025
Virtu Americas LLC
47.13K
0.09%
+47.13K
--
Sep 30, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Aug 17, 2022
Merger
15→1
Aug 17, 2022
Merger
15→1
Aug 17, 2022
Merger
15→1
Aug 17, 2022
Merger
15→1
Data
Data ex-dividendo
Tipo
Proporção
Aug 17, 2022
Merger
15→1
Aug 17, 2022
Merger
15→1
Aug 17, 2022
Merger
15→1
Aug 17, 2022
Merger
15→1
